Literature DB >> 32414735

Images of the month: Intractable vomiting and neuromyelitis optica spectrum disorder.

Seng Wee Cheo1, Qin Jian Low2, Yee Ann Tan3, Yuen Kang Chia3.   

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory disorder of the nervous system which can be potentially debilitating. Its prevalence is estimated to be around 0.5-10 per 100,000 population with predilection towards Asians and females. It can be diagnosed based on core clinical characteristics, serum aquaporin antibodies and neuroimaging features. It is important to pick up the diagnosis of NMOSD as the treatment is different from other demyelinating disease. Here, we illustrate a case of NMOSD presented with intractable vomiting. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  NMOSD; Neuromyelitis optica spectrum disorder; inflammatory disorder; neuroimaging; vomiting

Mesh:

Substances:

Year:  2020        PMID: 32414735      PMCID: PMC7354032          DOI: 10.7861/clinmed.2020-0019

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  5 in total

Review 1.  Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis.

Authors:  Bruna Garbugio Dutra; Antônio José da Rocha; Renato Hoffmann Nunes; Antônio Carlos Martins Maia
Journal:  Radiographics       Date:  2018 Jan-Feb       Impact factor: 5.333

Review 2.  MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

Authors:  Ho Jin Kim; Friedemann Paul; Marco A Lana-Peixoto; Silvia Tenembaum; Nasrin Asgari; Jacqueline Palace; Eric C Klawiter; Douglas K Sato; Jérôme de Seze; Jens Wuerfel; Brenda L Banwell; Pablo Villoslada; Albert Saiz; Kazuo Fujihara; Su-Hyun Kim
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

Review 3.  Neuromyelitis optica spectrum disorders.

Authors:  Saif Huda; Dan Whittam; Maneesh Bhojak; Jayne Chamberlain; Carmel Noonan; Anu Jacob
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

4.  Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.

Authors:  Remi A Kessler; Maureen A Mealy; Michael Levy
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

5.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.